# Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults

> **NCT02008344** · PHASE3 · COMPLETED · sponsor: **MDVI, LLC** · enrollment: 1161 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** favipiravir
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02008344
- **Lead sponsor:** MDVI, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 1161 (ACTUAL)
- **Last updated:** 2015-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008344, "Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02008344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*